Regulatory Investigations into Market Practices and Overbilling
EmergingAcceleratingLast updated: 25 March 2026
Retail Brands summary
CVS is under investigation by the House Judiciary for alleged antitrust violations and by the Florida Attorney General for unfair market practices and pharmacy steering. The brand also faces accusations of overbilling the federal government by $600 million.
Key facts
- Brand
- CVS Pharmacy
- Signal category
- Legal & Risk
- Current status
- Emerging
- Direction
- Accelerating
- Importance
- High
- Scope
- Regional
- Markets
- US
- Sources
- 3 (healthcaredive.com, ohiocapitaljournal.com and more)
- Last updated
- 25 March 2026
More CVS Pharmacy Legal & Risk signals
- Product Safety and Pharmacy Operational Compliance FailuresLegal & Risk · Emerging · 26 September 2026
CVS has been fined for understaffing and safety issues in its pharmacies and has initiated voluntary nationwide recalls of eye drops due to safety concerns, including lack of sterility assurance. Additionally, customers…
- Digital Privacy Litigation and AllegationsLegal & Risk · Emerging · 25 September 2026
CVS has recently settled a class action lawsuit for $20.5 million related to website tracking and digital privacy, and is currently facing allegations of HIPAA violations and a new class action lawsuit concerning illegal…
- Regulatory-Influenced Store ClosuresLegal & Risk · Emerging · 2 September 2026
CVS is undertaking nationwide store closures, with a specific warning of potential closures for 134 pharmacies in Tennessee, directly influenced by a new state bill. This indicates regulatory impact on physical footprint…
- Pharmacist Labor Disputes Over StaffingLegal & Risk · Emerging · 30 August 2026
Unionized CVS pharmacists in three states have initiated steps towards a strike, citing concerns over inadequate staffing levels, burnout, and stalled contract negotiations, which could impact pharmacy operations and…